The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Treatment of restless legs syndrome: An evidence‐based review and implications for clinical practice
Open accessAbstract
Only in the last three decades, the restless legs syndrome (RLS) has been examined in randomized controlled trials. The Movement Disorder Society (MDS) commissioned a task force to perform an evidence‐based review of the medical literature on treatment modalities used to manage patients with RLS. The task force performed a search of the published literature using electronic databases. The therapeutic efficacy of each drug was classified as being either efficacious, likely efficacious, investigational, nonefficacious, or lacking sufficient evidence to classify. Implications for clinical practice were generated based on the levels of evidence and particular features of each modality, such as adverse events. All studies were classed according to three levels of evidence. All Level‐I trials were included in the efficacy tables; if no Level‐I trials were available then Level‐II trials were included or, in the absence of Level‐II trials, Level‐III studies or case series were included. Only studies published in print or online before December 31, 2006 were included. All studies published after 1996, which attempted to assess RLS augmentation, were reviewed in a separate section. The following drugs are considered efficacious for the treatment of RLS: levodopa, ropinirole, pramipexole, cabergoline, pergolide, and gabapentin. Drugs considered likely efficacious are rotigotine, bromocriptine, oxycodone, carbamazepine, valproic acid, and clonidine. Drugs that are considered investigational are dihydroergocriptine, lisuride, methadone, tramadol, clonazepam, zolpidem, amantadine, and topiramate. Magnesium, folic acid, and exercise are also considered to be investigational. Sumanirole is nonefficacious. Intravenous iron dextran is likely efficacious for the treatment of RLS secondary to end‐stage renal disease and investigational in RLS subjects with normal renal function. The efficacy of oral iron is considered investigational; however, its efficacy appears to depend on the iron status of subjects. Cabergoline and pergolide (and possibly lisuride) require special monitoring due to fibrotic complications including cardiac valvulopathy. Special monitoring is required for several other medications based on clinical concerns: opioids (including, but not limited to, oxycodone, methadone and tramadol), due to possible addiction and respiratory depression, and some anticonvulsants (particularly, carbamazepine and valproic acid), due to systemic toxicities. © 2008 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Evidence-Based Medicine: How to Practice and Teach EBM
Sackett, D. L. (2000) · Cited by 5,950
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology
Allen, R. P., Picchietti, D., Hening, W. A., Trenkwalder, C., Walters, A. S., & Montplaisi, J. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(03)00010-8 · Cited by 2,900
Self-citationSystematic Reviews: Identifying relevant studies for systematic reviews
Dickersin, K., Scherer, R., & Lefebvre, C. (1994) · BMJ · doi:10.1136/bmj.309.6964.1286 · Cited by 2,256
Evidence-Based Medicine: How to Practice and Teach EBM
Satya-Murti, S. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.284.18.2382 · Cited by 1,643
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054830 · Cited by 884
Publication bias: evidence of delayed publication in a cohort study of clinical research projects
Stern, J. M., & Simes, R. J. (1997) · BMJ · doi:10.1136/bmj.315.7109.640 · Cited by 818
Winkelmann, J., Schormair, B., Lichtner, P., Ripke, S., Xiong, L., Jalilzadeh, S., Fulda, S., Pütz, B., Eckstein, G., Hauk, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2099 · Cited by 704
Self-citationA Genetic Risk Factor for Periodic Limb Movements in Sleep
Stefansson, H., Rye, D. B., Hicks, A., Petursson, H., Ingason, A., Thorgeirsson, T. E., Palsson, S., Sigmundsson, T., Sigurdsson, A. P., Eiriksdottir, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072743 · Cited by 630
Grégoire, G., Derderian, F., & Le Lorier, J. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00098-b · Cited by 526
Iron Status and Restless Legs Syndrome in the Elderly
O'KEEFFE, S. T., GAVIN, K., & LAVAN, J. N. (1994) · Age and Ageing · doi:10.1093/ageing/23.3.200 · Cited by 488
Augmentation of the Restless Legs Syndrome With Carbidopa/Levodopa
Allen, R. P., & Earley, C. J. (1996) · Sleep · doi:10.1093/sleep/19.3.205 · Cited by 451
Self-citationTreatment of restless legs syndrome with gabapentin: A double-blind, cross-over study
Garcia-Borreguero, D., Larrosa, O., de la Llave, Y., Verger, K., Masramon, X., & Hernandez, G. (2002) · Neurology · doi:10.1212/wnl.59.10.1573 · Cited by 405
Restless legs syndrome improved by pramipexole: A double-blind randomized trial
Montplaisir, J., Nicolas, A., Denesle, R., & Gomez-Mancilla, B. (1999) · Neurology · doi:10.1212/wnl.52.5.938 · Cited by 338
García-Borreguero, D., Allen, R. P., Kohnen, R., Högl, B., Trenkwalder, C., Oertel, W., Hening, W. A., Paulus, W., Rye, D., Walters, A., et al. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.03.022 · Cited by 285
Self-citationWalters, A. S., Wagner, M. L., Hening, W. A., Grasing, K., Mills, R., Chokroverty, S., & Kavey, N. (1993) · Sleep · doi:10.1093/sleep/16.4.327 · Cited by 283
Self-citationTrenkwalder, C., García-Borreguero, D., Montagna, P., Lainey, E., de Weerd, A. W., Tidswell, P., Saletu-Zyhlarz, G. M., Telstad, W., & Ferini‐Strambi, L. (2004) · PubMed · Cited by 283
Self-citationWoolf, S. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90073-x · Cited by 259
Exercise and Restless Legs Syndrome: A Randomized Controlled Trial
Aukerman, M. M., Aukerman, D., Bayard, M., Tudiver, F., Thorp, L., & Bailey, B. (2006) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.19.5.487 · Cited by 256
L-Dopa Therapy of Uremic and Idiopathic Restless Legs Syndrome: A Double-Blind, Crossover Trial
Trenkwalder, C., Stiasny, K., Pollmächer, T., Wetter, T., Schwarz, J., Kohnen, R., Kazenwadel, J., Krüger, H. P., Ramm, S., Küinzel, M., et al. (1995) · Sleep · doi:10.1093/sleep/18.8.681 · Cited by 253
Self-citationBrodeur, C., Montplaisir, J., Godbout, R., & Marinier, R. (1988) · Neurology · doi:10.1212/wnl.38.12.1845 · Cited by 223
Walters, A. S., Ondo, W. G., Dreykluft, T., Grunstein, R., Lee, D., Sethi, K., & on behalf of the TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group (2004) · Movement Disorders · doi:10.1002/mds.20257 · Cited by 221
Self-citationAugmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)
Winkelman, J. W., & Johnston, L. (2004) · Sleep Medicine · doi:10.1016/j.sleep.2003.07.005 · Cited by 217
A randomized controlled study of pergolide in patients with restless legs syndrome
Wetter, T. C., Stiasny, K., Winkelmann, J., Buhlinger, A., Brandenburg, U., Penzel, T., Medori, R., Rubin, M., Oertel, W. H., & Trenkwalder, C. (1999) · Neurology · doi:10.1212/wnl.52.5.944 · Cited by 215
Self-citationLong‐Term follow‐up on restless legs syndrome patients treated with opioids
Walters, A. S., Winkelmann, J., Trenkwalder, C., Fry, J. M., Kataria, V., Wagner, M., Sharma, R., Hening, W., & Li, L. (2001) · Movement Disorders · doi:10.1002/mds.1214 · Cited by 210
Self-citationAllen, R., Becker, P. M., Bogan, R., Schmidt, M., Kushida, C. A., Fry, J. M., Poceta, J. S., & Winslow, D. (2004) · Sleep · doi:10.1093/sleep/27.5.907 · Cited by 210
Self-citationSloand, J. A., Shelly, M. A., Feigin, A., Bernstein, P., & Monk, R. D. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.11.021 · Cited by 209
Trenkwalder, C., Beneš, H., Poewe, W., Oertel, W. H., Garcia-Borreguero, D., de Weerd, A. W., Ferini-Strambi, L., Montagna, P., Odin, P., Stiasny-Kolster, K., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70112-1 · Cited by 202
Self-citationEfficacy and safety of pramipexole in restless legs syndrome
Winkelman, J. W., Sethi, K. D., Kushida, C. A., Becker, P. M., Koester, J., Cappola, J. J., & Reess, J. (2006) · Neurology · doi:10.1212/01.wnl.0000231513.23919.a1 · Cited by 196
The treatment of restless legs syndrome with intravenous iron dextran
Earley, C. J., Heckler, D., & Allen, R. P. (2004) · Sleep Medicine · doi:10.1016/j.sleep.2004.03.002 · Cited by 193
Self-citationNORDLANDER, N. B. (1953) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1953.tb07042.x · Cited by 191
Amnestic sleep-related eating disorder associated with zolpidem
Morgenthaler, T. I., & Silber, M. H. (2002) · Sleep Medicine · doi:10.1016/s1389-9457(02)00007-2 · Cited by 185 · cited 1×
“However, there have been recent reports of parasomnias, including nocturnal eating syndrome and complex somnambulism which raise concerns about the introduction of abnormal sleep states in patients.(73,74) Implications for clinical research.”
BackgroundManagement of Parkinson's disease: An evidence-based review
Lang, A. E., & Lees, A. (2002) · Movement Disorders · doi:10.1002/mds.5554 · Cited by 184
A double‐blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome
Walters, A. S., Hening, W. A., Kavey, N., Chokroverty, S., & Gidro‐Frank, S. (1988) · Annals of Neurology · doi:10.1002/ana.410240318 · Cited by 175
Self-citationTreatment of the restless legs syndrome with carbamazepine: a double blind study.
Telstad, W., Sørensen, O., Larsen, S., Lillevold, P. E., Stensrud, P., & Nyberg-Hansen, R. (1984) · BMJ · doi:10.1136/bmj.288.6415.444 · Cited by 170
Gabapentin versus Ropinirole in the Treatment of Idiopathic Restless Legs Syndrome
Happe, S., Sauter, C., Klösch, G., Saletu, B., & Zeitlhofer, J. (2003) · Neuropsychobiology · doi:10.1159/000072882 · Cited by 163
Medication-related impulse control and repetitive behaviors in Parkinson??s disease
Voon, V., Potenza, M. N., & Thomsen, T. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32826fbc8f · Cited by 163
A Randomized, Double-Blind Placebo-Controlled Trial of Iron in Restless Legs Syndrome
Davis, B. J., Rajput, A., Rajput, M. L., Aul, E. A., & Eichhorn, G. R. (2000) · European Neurology · doi:10.1159/000008138 · Cited by 162
Methadone for refractory restless legs syndrome
Ondo, W. G. (2004) · Movement Disorders · doi:10.1002/mds.20359 · Cited by 149
Partinen, M., Hirvonen, K., Jama, L., Alakuijala, A., Hublin, C., Tamminen, I., Koester, J., & Reess, J. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.03.011 · Cited by 149
Collado-Seidel, V., Kazenwadel, J., Wetter, T. C., Kohnen, R., Winkelmann, J., Selzer, R., Oertel, W. H., & Trenkwalder, C. (1999) · Neurology · doi:10.1212/wnl.52.2.285 · Cited by 143
Self-citationPramipexole in the Management of Restless Legs Syndrome: An Extended Study
Silber, M. H., Girish, M., & Izurieta, R. (2003) · SLEEP · doi:10.1093/sleep/26.7.819 · Cited by 142
Bogan, R., Fry, J. M., Schmidt, M. H., Carson, S. W., & Ritchie, S. Y. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.1.17 · Cited by 141
Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome
Earley, C. J., Yaffee, J. B., & Allen, R. P. (1998) · Neurology · doi:10.1212/wnl.51.6.1599 · Cited by 139
Self-citationStiasny‐Kolster, K., Kohnen, R., Schollmayer, E., Möller, J. C., Oertel, W. H., & The Rotigotine Sp 666 Study Group (2004) · Movement Disorders · doi:10.1002/mds.20251 · Cited by 137
Self-citationEarley, C. J., Horská, A., Mohamed, M. A., Barker, P. B., Beard, J. L., & Allen, R. P. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2007.12.006 · Cited by 135
Self-citationA crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients
Thorp, M. L., Morris, C. D., & Bagby, S. P. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.25202 · Cited by 133
Oertel, W. H., Stiasny‐Kolster, K., Bergtholdt, B., Hallström, Y., Albo, J., Leissner, L. C., Schindler, T. M., Koester, J., & Reess, J. (2006) · Movement Disorders · doi:10.1002/mds.21261 · Cited by 131
Self-citationRandomized, Double-Blind, Placebo-Controlled Study of Clonidine in Restless Legs Syndrome
Wagner, M., Walters, A. S., Coleman, R., Hening, W., Grasing, K., & Chokroverty, S. (1996) · SLEEP · doi:10.1093/sleep/19.1.52 · Cited by 127
Self-citationPramipexole in the treatment of restless legs syndrome: a follow‐up study
Montplaisir, J. Y., Denesle, R., & Petit, D. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.0070s1027.x · Cited by 127
Clonazepam and vibration in restless legs syndrome
Montagna, P., Bianchi, L. S., Zucconi, M., Cirignotta, F., & Lugaresi, E. (1984) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb07826.x · Cited by 125
Self-citationAugmentation in restless legs syndrome is associated with low ferritin
Trenkwalder, C., Högl, B., Beneš, H., & Kohnen, R. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.07.020 · Cited by 125
Self-citationBeneš, H., Kurella, B., Kummer, J., Kazenwadel, J., Selzer, R., & Kohnen, R. (1999) · SLEEP · doi:10.1093/sleep/22.8.1073 · Cited by 125
Efficacy of pergolide in treatment of restless legs syndrome
Trenkwalder, C., Hundemer, H., Lledó, A., Swieca, J., Polo, O. J., Wetter, T. C., Ferini‐Strambi, L., de Groen, H., Quail, D., & Brandenburg, U. (2004) · Neurology · doi:10.1212/01.wnl.0000124465.20878.84 · Cited by 113
Self-citationHornyak, M., Voderholzer, U., Hohagen, F., Berger, T., & Riemann, D. W. (1998) · SLEEP · doi:10.1093/sleep/21.5.501 · Cited by 109
Oertel, W. H., Beneš, H., Garcı́a-Borreguero, D., Geisler, P., Högl, B., Saletu, B., Trenkwalder, C., Sommerville, K. W., Schollmayer, E., Kohnen, R., et al. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.04.010 · Cited by 109
Self-citationEffective cabergoline treatment in idiopathic restless legs syndrome
Stiasny‐Kolster, K., Beneš, H., Peglau, I., Hornyak, M., Holinka, B., Wessel, K., Emser, W., Leroux, M., Kohnen, R., & Oertel, W. H. (2004) · Neurology · doi:10.1212/01.wnl.0000147297.51023.c8 · Cited by 108
Self-citationRopinirole for restless legs syndrome
Adler, C. H., Hauser, R. A., Sethi, K. D., Caviness, J. N., Marlor, L., Anderson, W. M., & Hentz, J. G. (2004) · Neurology · doi:10.1212/01.wnl.0000120672.94060.f1 · Cited by 107
Garcı́a-Borreguero, D., Kohnen, R., Högl, B., Ferini‐Strambi, L., Hadjigeorgiou, G. M., Hornyak, M., de Weerd, A., Happe, S., Stiasny‐Kolster, K., Gschliesser, V., et al. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.03.023 · Cited by 107
Self-citationTrenkwalder, C., Beneš, H., Grote, L., Happe, S., Högl, B., Mathis, J., Saletu-Zyhlarz, G. M., Kohnen, R., & CALDIR study group (2007) · Movement Disorders · doi:10.1002/mds.21401 · Cited by 106
Self-citationMıcozkadıoğlu, H., Özdemir, F. N., Kut, A., Sezer, S., Saatçi, U., & Haberal, M. A. (2004) · Renal Failure · doi:10.1081/jdi-120039823 · Cited by 102
The Treatment of the Restless Legs Syndrome with Clonazepam: A Prospective Controlled Study
Boghen, D., Lamothe, L., Elie, R., Godbout, R., & Montplaisir, J. Y. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100036350 · Cited by 99
Montplaisir, J. Y., Karrasch, J., Haan, J., & Volc, D. (2006) · Movement Disorders · doi:10.1002/mds.21050 · Cited by 97
Treatment of Restless Legs Syndrome With Tramadol
Lauerma, H., & Markkula, J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0407 · Cited by 95
First night efficacy of pramipexole in restless legs syndrome and periodic leg movements
Manconi, M., Ferri, R., Zucconi, M., Oldani, A., Fantini, M. L., Castronovo, V., & Ferini‐Strambi, L. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.10.008 · Cited by 95
Bliwise, D. L., Freeman, A. A. H., Ingram, C. D., Rye, D. B., Chakravorty, S., & Watts, R. L. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2004.12.002 · Cited by 94
Systematic Reviews: Synthesis of Best Evidence for Health Care Decisions
Bundrick, J. B. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.12.1229-a · Cited by 93
Restless legs syndrome augmentation associated with tramadol
Earley, C. J., & Allen, R. P. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.05.011 · Cited by 91
Self-citationL-DOPA/Carbidopa for Nocturnal Movement Disorders in Uremia
Walker, S. L., Fine, A., & Kryger, M. H. (1996) · SLEEP · doi:10.1093/sleep/19.3.214 · Cited by 91
Eisensehr, I., Ehrenberg, B. L., Solti, S. R., & Noachtar, S. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0367-6 · Cited by 89
Trenkwalder, C., Stiasny‐Kolster, K., Kupsch, A. R., Oertel, W. H., Koester, J., & Reess, J. (2006) · Movement Disorders · doi:10.1002/mds.20983 · Cited by 85
Self-citationRestless legs syndrome augmentation and pramipexole treatment
Ferini‐Strambi, L. (2002) · Sleep Medicine · doi:10.1016/s1389-9457(02)00144-2 · Cited by 80
Staedt, J., Waβmuth, F., Ziemann, U., Hajak, G., Rüther, E., & Stoppe, G. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277664 · Cited by 73
Epidemiological assessment of drug-induced disease
Kaufman, D. W., & Shapiro, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02826-9 · Cited by 72
García-Borreguero, D., Grunstein, R. R., Sridhar, G., Dreykluft, T., Montagna, P., Dom, R., Lainey, E., Moorat, A., & Roberts, J. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.09.009 · Cited by 72
Self-citationHornyak, M., Grossmann, C., Kohnen, R., Schlatterer, M., Richter, H., Voderholzer, U., Riemann, D., & Berger, M. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.138867 · Cited by 71
Pleuropulmonary Disease Due to Pergolide Use for Restless Legs Syndrome
Danoff, S. K., Grasso, M. E., Terry, P. B., & Flynn, J. A. (2001) · CHEST Journal · doi:10.1378/chest.120.1.313 · Cited by 70
Pregabalin in restless legs syndrome with and without neuropathic pain
Sommer, M., Bachmann, C. G., Liebetanz, K. M., Schindehütte, J., Tings, T., & Paulus, W. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00796.x · Cited by 69
Encouraging initial response of restless legs syndrome to pramipexole
Becker, P. M., Ondo, W. G., & Sharon, D. (1998) · Neurology · doi:10.1212/wnl.51.4.1221 · Cited by 69
Efficacy of cabergoline in restless legs syndrome
Oertel, W. H., Beneš, H., Bodenschatz, R., Peglau, I., Warmuth, R., Happe, S., Geisler, P., Cassel, W., Leroux, M., Kohnen, R., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000237742.08297.22 · Cited by 68
Self-citationFolate-Responsive Neurological and Mental Disorders: Report of 16 Cases
Botez, M. I., Fontaine, F. S., Botez-Marquard, T., & Bachevalier, J. (2008) · European Neurology · doi:10.1159/000114904 · Cited by 67
Beneš, H., Heinrich, C. R., Ueberall, M. A., & Kohnen, R. (2004) · SLEEP · doi:10.1093/sleep/27.4.674 · Cited by 66
Carbamazepine in restless legs
Lundvall, O., �bom, P. E., & Holm, R. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf01037942 · Cited by 66
Compulsive activity and anterograde amnesia after zolpidem use
Tsai, M., Tsai, Y., & Huang, Y. (2007) · Clinical Toxicology · doi:10.1080/15563650600956741 · Cited by 61
Amantadine is beneficial in restless legs syndrome
Evidente, V. G. H., Adler, C. H., Caviness, J. N., Hentz, J. G., & Gwinn, K. A. (2000) · Movement Disorders · Cited by 51
Levodopa for idiopathic restless legs syndrome: Evidence‐based review
Conti, C. F., de Oliveira, M. M., Andriolo, R. B., Saconato, H., Atallah, Á. N., Valbuza, J. S., de Carvalho, L. B. C., & do Prado, G. F. (2007) · Movement Disorders · doi:10.1002/mds.21662 · Cited by 40
Beneš, H. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.05.007 · Cited by 40
Safety of pramipexole in patients with restless legs syndrome
Stiasny, K., Möller, J. C., & Oertel, W. H. (2000) · Neurology · doi:10.1212/wnl.55.10.1589 · Cited by 39
Self-citationLang, A. E., & Lees, A. J. (2002) · Movement Disorders · doi:10.1002/mds.10108 · Cited by 34
Zolpidem in Restless Legs Syndrome
Bezerra, M. L. S., & Martínez, J. V. (2002) · European Neurology · doi:10.1159/000065514 · Cited by 31
Treatment of restless legs syndrome with the dopamine agonist alpha‐dihydroergocryptine
Tergau, F., Wischer, S., Wolf, C., & Paulus, W. (2001) · Movement Disorders · doi:10.1002/mds.1141 · Cited by 24
[Topiramate use as treatment in restless legs syndrome].
Bravo, A. (2004) · PubMed · Cited by 22
Entacapone Prolongs the Reduction of PLM by Levodopa/Carbidopa in Restless Legs Syndrome
Polo, O. J., Ylä-Sahra, R., Hirvonen, K., Karvinen, J., Vahteristo, M., & Ellmén, J. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31805930c2 · Cited by 11
Cited by
Earley, C. J., Connor, J., Garcia-Borreguero, D., Jenner, P., Winkelman, J., Zee, P. C., & Allen, R. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.05.009 · Cited by 336
Self-citationRestless legs syndrome: pathophysiology, clinical presentation and management
Trenkwalder, C., & Paulus, W. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.55 · Cited by 310
Self-citationGarcia-Borreguero, D., Kohnen, R., Silber, M. H., Winkelman, J. W., Earley, C. J., Högl, B., Manconi, M., Montplaisir, J., Inoue, Y., & Allen, R. P. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2013.05.016 · Cited by 291
Self-citationComorbidities, treatment, and pathophysiology in restless legs syndrome
Trenkwalder, C., Allen, R., Högl, B., Clemens, S., Patton, S., Schormair, B., & Winkelmann, J. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30311-9 · Cited by 275
Self-citationTreatment of hyperkinetic movement disorders
Jankovic, J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70183-8 · Cited by 252
Metadata
- Authors
- Trenkwalder, C., Hening, W. A., Montagna, P., Oertel, W. H., Allen, R. P., Walters, A. S., Costa, J., Stiasny‐Kolster, K., & Sampaio, C.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2008-10-16
- Volume
- 23
- Issue
- 16
- Pages
- 2267-2302
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2085792179
- Cited by
- 264
- References
- 93
- FWCI
- 22.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.